Page last updated: 2024-10-22

amiodarone and Carcinogenesis

amiodarone has been researched along with Carcinogenesis in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lan, SH1
Wu, SY1
Zuchini, R1
Lin, XZ1
Su, IJ1
Tsai, TF1
Lin, YJ1
Wu, CT1
Liu, HS1

Other Studies

1 other study available for amiodarone and Carcinogenesis

ArticleYear
Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:2

    Topics: Amiodarone; Animals; Autophagy; Carcinogenesis; Carcinoma, Hepatocellular; Disease Models, Animal; D

2014